Recruiting
Phase 2

Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer

Sponsor:

Academic and Community Cancer Research United

Code:

NCT04660760

Conditions

Clinical Stage III Gastric Cancer AJCC v8

Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8

Clinical Stage IV Gastric Cancer AJCC v8

Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8

Clinical Stage IVA Gastric Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Paclitaxel

Quality-of-Life Assessment

Ramucirumab

Trifluridine and Tipiracil Hydrochloride

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information